CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Horizon Discovery Group PLC is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Horizon Discovery Group PLC
8100 Cambridge Research Park
Beach Drive
Phone: +44 1223976000p:+44 1223976000 Cambridge, CB25 9TL  United Kingdom Fax: +44 1223655581f:+44 1223655581
This company is no longer actively traded on any major stock exchange.
Business Summary
Horizon Discovery Group plc is a United Kingdom-based life science company. The Company uses gene editing and gene modulation application. Through the application of these technologies the Company enables researchers to alter almost any gene or modulate its function in human or mammalian cells to generate models that mimic the genetic abnormalities found in diseases such as cancer. Horizon offers a catalogue of over 1,000,000 cell and reagent products, which along with related research services, support a greater understanding of the function of genes across all species and the genetic drivers of disease, and the development of personalized molecular, cell and gene therapies.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202012/31/2019Yes----

Industries
SIC Code Description
2836 Biological products, except diagnostic substances
8071 Medical laboratories
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Non-Executive Chairman of the Board IanGilham 3/5/2014 3/5/2014
Chief Executive Officer, Executive Director Terence W.Pizzie 57 5/8/2018 5/8/2018
Chief Financial Officer, Executive Director, Secretary JayeshPankhania 1/29/2019 1/29/2019
10 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
COMBINATORX INCORPORATED 650 ALBANY STREET BOSTON MA USA

Business Names
Business Name
COMBINATORX INCORPORATED
High Throughput Screening
Horizon CombinatoRx
8 additional Business Names available in full report.

General Information
Number of Employees: 416 (As of 12/31/2019)
Outstanding Shares: 164,214,591 (As of 12/22/2020)
Stock Exchange: LON
Fax Number: +44 1223655581


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, December 31, 2023